Navigation Links
Pharmasset Reports Fiscal Year End 2011 Financial Results
Date:11/14/2011

cause our actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 30, 2011 and our Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission and discussions of potential risks, uncertainties, and other important factors in our subsequent filings with the Securities and Exchange Commission.

PHARMASSET, INC. STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS(in thousands, except share and per share amounts)Years Ended September 30,201120102009Revenues

$
897$
,020$
3,293COSTS AND EXPENSES:  Research and development

75,85048,26152,552  General and administrative

16,65116,45813,365Total costs and expenses

92,50164,71965,917Operating loss

(91,604)(63,699)(52,624)Investment income

158221Other income

489--Interest expense

(1,058)(2,391)(3,190)Loss before income taxes

(92,158)(66,082)(55,593)Provision (benefit) for income taxes

(973)--Net loss

$
(91,185)$
(66,082)$
(55,593)COMPREHENSIVE LOSS:  Net loss

$
(91,185)$
(66,082)$
(55,593)  Unrealized gain on available-for-sale investments

--3Comprehensive loss

$
(91,185)$
(66,082)$
(55,590)NET LOSS PER SHARE:  Basic and diluted

$
(1.25)$
(1.07)$
(1.05)WEIGHTED AVERAGE SHARES OUTSTANDING:  Basic and diluted

72,776,98161,909,96652,959,064PHARMASSET, INC.BALANCE SHEETS(in thousands, except par value, share and per share amounts)As of September 30,20112010ASSETSCURRENT ASSETS:  Cash and cash equivalents

$ 166,455$ 127,081  Amounts due from collaboration partner

-6  Prepaid expenses and other assets

3,528718Total current assets

169,983127,805EQUIPMENT AND LEASEHOLD IMPROVEMENTS:  Equipment

4,8114,060  Leasehold improvements'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
2. Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences
3. Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
4. Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th
5. Pharmasset to Present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th
6. Pharmasset to Present at Two Upcoming Investor Conferences
7. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
8. Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock
9. Pharmasset Reports Fiscal First Quarter 2009 Financial Results
10. InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25
11. Pharmasset Reports Fiscal Second Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Empowering biomedical researchers with richer, more ... today announced its MR Compatible Small Animal PET ... uses silicon photomultiplier detector technology, so it can ... manufacturers like Bruker and Agilent,” said James Schellenberg, ... enables simultaneous PET and MRI data acquisition with ...
(Date:5/27/2015)... , May 27, 2015  US-Australian drug discovery and development ... today that it will present at the Brain Tumor Biotech ... on May 29, 2015. The venue is the Lennox ... . The Brain Tumor Biotech Summit ... pharmaceutical industry and the investment community to promote innovative new ...
(Date:5/26/2015)... Regenestem Network has announced the ... Buenos Aires, Argentina. The clinic will be lead by ... has assembled a multidisciplinary team of medical professionals who ... Puerto Madero office. , The new Regenestem Network ... clinical studies in cellular therapies, and establish Regenestem protocols ...
(Date:5/26/2015)... May 26, 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... and CEO, will provide an update on the progress of ... of the company,s business strategy at 1:30pm ET on Monday, ... The conference is being held in New York, ... live and may be accessed via a link on the ...
Breaking Biology Technology:Cubresa Launches Simultaneous PET/MRI Technology 2Novogen to Present at Brain Tumor Biotech Summit 2015 2Novogen to Present at Brain Tumor Biotech Summit 2015 3Novogen to Present at Brain Tumor Biotech Summit 2015 4Novogen to Present at Brain Tumor Biotech Summit 2015 5Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference 2
... Information technology professionals in Wisconsin announced on Monday the ... a forum for information exchange and issue advocacy ... revenue and hires more than 55,000 employees, according to ... of which approximately a third are IT companies. The ...
... firing workers. Great businesses however are skilled at ... grow their experience, stretch their abilities and enable ... agility across jobs and organizational boundaries is the ... their talent. , ,It is surprising how ...
... head of GE Healthcare Technologies in Waukesha, will become president ... year as part of the parent company's effort to reorganize ... Castell as head of GE Healthcare in 2006. Hogan ... Healthcare Technologies division since 2000, when he succeeded Jeff Immelt ...
Cached Biology Technology:Statewide IT association will address IT issues and priorities 2Statewide IT association will address IT issues and priorities 3Agility is the next talent management imperative 2Agility is the next talent management imperative 3Agility is the next talent management imperative 4
(Date:5/25/2015)... , May 25, 2015  Australia,s market for ... stage, although 2014 saw the advent of several trials ... 24 April 2015 is expected to ignite interest in ... in Australia . This in turn ... industry and drive new partnerships amongst vendors and distributors. ...
(Date:5/22/2015)... -- According to a new market research ... Emotion, Forensic), by Software (Middleware, Databases), by Hardware (Cameras, Integrated ... Home) - Global Forecast to 2020", published by MarketsandMarkets, ... 2015 to $6.19 Billion by 2020, at a CAGR ... Tables and   43 Figures spread through 140 Pages ...
(Date:5/21/2015)... The Sync Project™ , a global collaboration harnessing ... a collaborative partnership with Berklee,s Institute for Creative ... on original research, joint course development and an internship ... Sync Project and BerkleeICE are exploring the launch of ... academic year.  The course will focus ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... a decade, the drug called tPA has proven its worth ... kind of stroke. But its promise is blemished by two ... its brain-saving power fades fast after the third hour of ... Nature Medicine reveals why tPA has these limitations. ...
... 2008 A Webinar hosted by TorreyPines Therapeutics, Inc. ... will bring together industry experts to discuss the ... through the inhibition of the neurotransmitter glutamate. The ... will moderate a discussion following brief presentations by: ...
... female red squirrels showed high levels of multimale mating ... genetic relatedness, basically mating with their relatives. ... Canada and the University of Sheffield in Sheffield, England, ... a period of three years near Kluane National Park ...
Cached Biology News:Stroke study reveals key target for improving treatment and suggests that Gleevec may help 2Stroke study reveals key target for improving treatment and suggests that Gleevec may help 3Stroke study reveals key target for improving treatment and suggests that Gleevec may help 4Treating chronic pain, migraine & muscle spasticity through inhibition of neurotransmitter glutamate 2Treating chronic pain, migraine & muscle spasticity through inhibition of neurotransmitter glutamate 3
... CE-based system provides clear advantages over ... load, gene expression), mutation analysis, and ... system with microplate connectivity is ideal ... quality control. The P/ACE Series ...
The imaging screen-K (Kodak), tritium, is a 20 x 25 cm storage phosphor screen that is used for the quantitation and imaging of 32P, 33P, 35S, 14C, and 3H....
The optional fixed lens, 105 mm, is for use with the VersaDoc imaging systems for imaging small samples at high resolution....
The filter 640DF35 for the Molecular Imager FX is a band pass filter for Texas Red dye....
Biology Products: